Amarin reported $310.5M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 409.03B 81.15B Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amarin USD 341M 4M Sep/2025
AstraZeneca USD 233.07B 17.56B Sep/2025
DBV Technologies USD 274M 17M Sep/2025
GlaxoSmithKline GBP 64.04B 7.8B Sep/2025
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
Novartis USD 265.66B 9.48B Sep/2025